BRPI0517647A - combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina - Google Patents

combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina

Info

Publication number
BRPI0517647A
BRPI0517647A BRPI0517647-6A BRPI0517647A BRPI0517647A BR PI0517647 A BRPI0517647 A BR PI0517647A BR PI0517647 A BRPI0517647 A BR PI0517647A BR PI0517647 A BRPI0517647 A BR PI0517647A
Authority
BR
Brazil
Prior art keywords
combinations
alpha
receptor agonists
nicotinically
acetylcholine receptor
Prior art date
Application number
BRPI0517647-6A
Other languages
English (en)
Inventor
Hans O Kalkman
Joachim Nozulak
Annick Vassout
Konstanze Hurth
Dominik Feuerbach
Conrad Gentsch
Graeme Bilbe
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0517647A publication Critical patent/BRPI0517647A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMBINAçõES DE AGONISTAS DO RECEPTOR NICOTìNICO ALFA 7 DE ACETILCOLINA. A presente invenção refere-se a combinações que compreendem pelo menos um agonista do receptor nicotínico alfa 7 de acetilcolina e pelo menos um composto selecionado a partir do grupo que consiste em (a) antipsicóticos convencionais (b) antipsicóticos atípicos (c) intensificadores de memória e/ou atenção, cognição (d) e para uso destas combinações no tratamento de distúrbios psiquiátricos.
BRPI0517647-6A 2004-11-05 2005-11-03 combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina BRPI0517647A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0424564A GB0424564D0 (en) 2004-11-05 2004-11-05 Organic compounds
PCT/EP2005/011787 WO2006048294A1 (en) 2004-11-05 2005-11-03 Combinations of nicotinic acetylcholine alpha 7 receptor agonists

Publications (1)

Publication Number Publication Date
BRPI0517647A true BRPI0517647A (pt) 2008-10-14

Family

ID=33523294

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0517647-6A BRPI0517647A (pt) 2004-11-05 2005-11-03 combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina

Country Status (12)

Country Link
US (2) US20080306081A1 (pt)
EP (3) EP2135609A1 (pt)
JP (3) JP2008518896A (pt)
KR (2) KR20130024974A (pt)
CN (1) CN101039670A (pt)
AU (1) AU2005300691A1 (pt)
BR (1) BRPI0517647A (pt)
CA (1) CA2582436C (pt)
GB (1) GB0424564D0 (pt)
MX (1) MX2007005428A (pt)
RU (1) RU2007120690A (pt)
WO (1) WO2006048294A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
US20060211686A1 (en) * 2005-03-18 2006-09-21 Abbott Laboratories Alpha7 Neuronal nicotinic receptor ligand and antipsychotic compositions
EP2258358A3 (en) * 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
GB0521508D0 (en) 2005-10-21 2005-11-30 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
MX2010009290A (es) * 2008-02-29 2010-09-14 Biolab Sanus Farmaceutica Ltda Composicion farmaceutica.
JO3250B1 (ar) * 2009-09-22 2018-09-16 Novartis Ag إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
CN103260619A (zh) * 2010-07-26 2013-08-21 英维沃医药有限公司 利用某些α-7烟酸受体激动剂与乙酰胆碱酯酶抑制剂的组合治疗认知障碍
ES2716865T3 (es) * 2011-02-18 2019-06-17 Scripps Research Inst Diferenciación dirigida de células precursoras de oligodendrocitos a un destino celular mielinizante
WO2012127393A1 (en) * 2011-03-18 2012-09-27 Novartis Ag COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
AU2021387993A1 (en) * 2020-11-25 2023-06-08 Vanda Pharmaceuticals Inc. Treatment of public speaking anxiety with an alpha-7 nicotinic acetylcholine receptor agonist

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB261309A (en) 1926-07-23 1926-11-18 Oswald Pfeiffer Improvements in collapsible grids
GB281309A (en) 1926-11-27 1928-03-29 Inventia Patent Verwert Ges Improvements in or relating to brushing machines having replaceable brush members
US3310553A (en) 1962-09-25 1967-03-21 Pfizer & Co C Alkylated thioxathenesulfonamides
US3539573A (en) 1967-03-22 1970-11-10 Jean Schmutz 11-basic substituted dibenzodiazepines and dibenzothiazepines
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
SE9600683D0 (sv) * 1996-02-23 1996-02-23 Astra Ab Azabicyclic esters of carbamic acids useful in therapy
SE9903760D0 (sv) 1999-10-18 1999-10-18 Astra Ab New compounds
SE0000540D0 (sv) 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
GB0010955D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
PE20021019A1 (es) * 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
AR036040A1 (es) * 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
JP2005511613A (ja) * 2001-11-08 2005-04-28 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー 疾患治療用アザビシクロ置換ヘテロアリール化合物
EP1542999A1 (en) * 2002-08-01 2005-06-22 Pharmacia & Upjohn Company LLC 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
ATE384720T1 (de) 2002-08-14 2008-02-15 Neurosearch As Chinucledin - derivate und deren verwendung
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
AU2003284898A1 (en) * 2002-10-29 2004-05-25 Micro, Inc. Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer's disease
EA200500783A1 (ru) * 2002-12-11 2005-12-29 ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи Комбинация для лечения синдрома дефицита внимания с гиперактивностью
FR2931677B1 (fr) * 2008-06-02 2010-08-20 Sanofi Aventis Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
WO2010022556A1 (zh) 2008-08-27 2010-03-04 中兴通讯股份有限公司 一种下行信号的分扇区处理方法及基站
US10066977B2 (en) 2009-01-26 2018-09-04 Canon U.S. Life Sciences, Inc. Microfluidic flow monitoring

Also Published As

Publication number Publication date
CA2582436C (en) 2016-10-04
JP2008518896A (ja) 2008-06-05
MX2007005428A (es) 2007-05-18
EP1809285A1 (en) 2007-07-25
EP2332537A1 (en) 2011-06-15
EP2135609A1 (en) 2009-12-23
GB0424564D0 (en) 2004-12-08
JP2014196328A (ja) 2014-10-16
KR20130024974A (ko) 2013-03-08
KR101302898B1 (ko) 2013-09-06
RU2007120690A (ru) 2008-12-10
CN101039670A (zh) 2007-09-19
KR20070073881A (ko) 2007-07-10
US20100125063A1 (en) 2010-05-20
US20080306081A1 (en) 2008-12-11
WO2006048294A1 (en) 2006-05-11
JP2012255039A (ja) 2012-12-27
CA2582436A1 (en) 2006-05-11
AU2005300691A1 (en) 2006-05-11

Similar Documents

Publication Publication Date Title
BRPI0517647A (pt) combinações de agonistas do receptor nicotìnico alfa 7 de acetilcolina
CL2007001734A1 (es) Compuestos derivados de imidazol condensados con heterociclos nitrogenados; composicion farmaceutica; y uso para tratar o prevenir la enfermedad de alzheimer, demencia senil y demencia asociada con enfermedad de parkinson entre otras.
ATE526318T1 (de) Farnesoid-x-rezeptor-agonisten
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
CL2012002521A1 (es) Composicion farmaceutica que comprende un inhibidor de dpp iv seleccionado de un grupo definido, un primer diluyente, un segundo diluyente: manitol, un segundo diluyente: almidon pregelatinizado, un aglutinante y un lubricante; util en el tratamiento de diabetes. (divisional de la sol. 1260-07).
BR0317110A (pt) Tratamento de doenças com combinações de agonistas do receptor nicotìnico da acetilcolina alfa 7 e outros compostos
MA29369B1 (fr) Dosage fixe d'anticorps anti-her
CY1113734T1 (el) Χημικες ενωσεις
WO2007070359A3 (en) Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
CY1113076T1 (el) Κρυσταλλικες μορφες του 4-μεθυλο-ν-[3-(4-μεθυλ-ιμιδαζολ-1-υλ)-5-τριφθορομεθυλο-φαινυλο]-3-(4-πυριδιν-3-υλ-πυριμιδιν-2-υλαμινο)-βενζαμιδιου
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
BRPI0620436B8 (pt) compostos miméticos de lisina modificados, composição farmacêutica e uso
ATE314371T1 (de) Spiro-indole als y5-rezeptor antagonisten
DK1199069T3 (da) Anvendelse af en estrogenagonist/-antagonist til forbedring eller bibeholdelse af urogenital sundhed
BRPI0515012A (pt) substáncia quìmica, composição e formulação farmacêutica, método de tratamento, método de inibição de pelo menos uma enzima que utiliza atp e uso
ATE528302T1 (de) 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin- kinasen nützlich sind
DK1316801T3 (da) Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer
GT200500246A (es) Combinacion de compuestos organicos
BRPI0515721A (pt) uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação
ATE304533T1 (de) Tetrahydrochinolinderivate als muscarinische agonisten
BRPI0606081A (pt) método e sistema para impor restrições sobre sessões
PE20071364A1 (es) Procedimiento para tratar perdida de peso no deseada o trastornos alimentarios administrando un agonista de trkb
ATE467128T1 (de) Kolloidale metallkonjugate
BRPI0519669A2 (pt) método e dispositivo para compartilhamento de informação de conteúdo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]